Details for Patent: 8,324,283
✉ Email this page to a colleague
Which drugs does patent 8,324,283 protect, and when does it expire?
Patent 8,324,283 protects GILENYA and is included in one NDA.
Protection for GILENYA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has ninety-nine patent family members in forty-two countries.
Summary for Patent: 8,324,283
| Title: | Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol |
| Abstract: | A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor agonist; and (b) a sugar alcohol. |
| Inventor(s): | Oomura; Tomoyuki (Oita, JP), Pudipeddi; Madhusudhan (Edison, NJ), Ruegger; Colleen (Morris Plains, NJ), Royce; Alan E (Saylorsburg, PA), Sasaki; Masaki (Oita, JP), Tamura; Tokuhiro (Fukuoka, JP) |
| Assignee: | Novartis AG (Basel, CH) Mitsubishi Pharma Corporation (Osaka, JP) |
| Application Number: | 12/189,323 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,324,283 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; Use; |
More… ↓ |
Drugs Protected by US Patent 8,324,283
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | GILENYA | fingolimod hydrochloride | CAPSULE;ORAL | 022527-001 | Sep 21, 2010 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,324,283
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1613288 | ⤷ Subscribe | C300497 | Netherlands | ⤷ Subscribe |
| European Patent Office | 1613288 | ⤷ Subscribe | C20110013 00043 | Estonia | ⤷ Subscribe |
| European Patent Office | 1613288 | ⤷ Subscribe | PA2011010 | Lithuania | ⤷ Subscribe |
| European Patent Office | 1613288 | ⤷ Subscribe | CA 2011 00023 | Denmark | ⤷ Subscribe |
| European Patent Office | 1613288 | ⤷ Subscribe | 91867 | Luxembourg | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
